Tuesday, August 19, 2003

Record Number of Abstracts Accepted for the 9th World Congress on Gastrointestinal Cancer&#174

Record Number of Abstracts Accepted for the 9th World Congress on Gastrointestinal Cancer®

More than 400 abstracts have been accepted for presentation at the 9th World Congress on Gastrointestinal Cancer® in Barcelona, Spain from 27-30 June 2007, representing the latest research from across the globe in colon, esophageal, gastric, liver, pancreatic and rectal cancer. The Congress, presented by Imedex Medical Education, in partnership with the European Society for Medical Oncology (ESMO), is the premier platform for specialists in cancer research, leading oncologists and practicing clinicians to review the state-of-the-art in gastrointestinal cancer and share the latest information on its multidisciplinary management. 3,500 healthcare providers from 100 different countries are expected to attend.

Barcelona, Spain (PRWEB) March 17, 2007

More than 400 abstracts have been accepted for presentation at the 9th World Congress on Gastrointestinal Cancer® in Barcelona, Spain from 27-30 June 2007, representing the latest research from across the globe in colon, esophageal, gastric, liver, pancreatic and rectal cancer. The Congress, presented by Imedex Medical Education, in partnership with the European Society for Medical Oncology (ESMO), is the premier platform for specialists in cancer research, leading oncologists and practicing clinicians to review the state-of-the-art in gastrointestinal cancer and share the latest information on its multidisciplinary management. 3,500 healthcare providers from 100 different countries are expected to attend.

The internationally recognized faculty will include Aaron Ciechanover, MD, DSc, laureate of the 2004 Nobel Prize in Chemistry. 55 additional experts will participate in the scientific program, chaired by Mario Dicato, MD of the Luxembourg Medical Center in Luxembourg and Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium.

The scientific agenda is enhanced this year by expanded meet the expert sessions, providing attendees the extended opportunity to interact with leading specialists. The Congress will also introduce a new nurses program, featuring topics of special interest to oncology nurses, and an expert consensus report on rectal cancer. Continuing the successful initiative begun in 2006, a Saturday morning session will focus on young medical oncologists, providing information relevant to new practitioners in the field, and a dedicated surgery session will provide the latest information for surgical oncologists.

About Imedex Medical Education

Based in Alpharetta, Georgia, USA, Imedex Medical Education. (www. imedex. com) is an industry leader in providing accredited medical education services. With more than 22 years experience in medical education, Imedex Medical Education concentrates on developing proprietary independent CME programs worldwide and collaborates with medical associations and health care companies to produce a full range of medical education products. With innovative and focused scientific programs, Imedex continually exceeds the expectations of thousands of physicians, researchers, nurses and pharmaceutical representatives each year.

Imedex Medical Education has extensive relationships with leading healthcare professionals and opinion leaders in many fields of medicine. Imedex provides a fully staffed medical resource department as well as in-house business development, project management, marketing and graphic and web-design services. Founded in 1985 in The Netherlands, Imedex established its US-based operations in 1987.

About the European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) is the leading European non-profit, professional organization for medical oncology with a focus on promoting multidisciplinary cancer treatment around the world.

ESMO unites medical oncologists, oncology specialists, healthcare professionals, caregivers, patients and policy makers in a global alliance committed to eradicating cancer and ensuring equal access to high quality treatment for all patients. Through state-of-the-art education and training programs, ESMO plays an instrumental role in providing the oncology community with the most up-to-date scientific research and information available. ESMO publishes articles on all aspects of clinical oncology through its flagship journal, Annals of Oncology. ESMO is dedicated to educating and supporting oncologists, optimizing patient care, disseminating cancer-specific information to the public, and advocating patient rights. As an authoritative voice in the fight against cancer, ESMO provides both the platform and the consultative expertise to influence national and international organizations as well as European authorities, in order to establish common standards for a multidisciplinary approach to cancer treatment. More information about ESMO and its activities can be found at www. esmo. org.

CONTACT:

Josh Jacobs

Imedex Medical Education

Education is the best medicine®

(+1) 770 751 7332

# # #